The customer magazine of the special maschine builder L.B. Bohle from Ennigerloh/Germany is published twice a year.
Ennigerloh Ahead of the Global Game Continuous Pharmaceutical Manufacturing: more than 30 experts from Asia, Europe, South and North America at the technical symposium. L.B. Bohle’s concentrated pharmaceutical know-how: The Chairman of the Advisory Board Lorenz B. Bohle, Martin Hack (Vice President L.B. Bohle LLC) and Andreas Altmeyer (Head of Service Center), from left to right, are following the results of the test runs with satisfaction. For two days in the fall of 2017, Ennigerloh was the place to be for experts and users in the pharmaceutical industry doing research in the area of continuous manufacturing: They accepted the invitation of L.B. Bohle Maschinen + Verfahren GmbH to the “Continuous Pharmaceutical Manufacturing Symposium“ to discuss the processes of the future. “We are in constant exchange with scientists from all over the globe and are at the technological forefront when it comes to continuous processes for the pharmaceutical industry,” reports Tim Remmert, Managing Director. “For pharmaceutical manufacturers, continuous manufacturing means shorter time to market, more flexible production even of small batches and highest precision and quality due to comprehensive process monitoring and control,” added Thorsten Wesselmann, Technical Director. “This saves time and costs for our customers in the pharmaceutical industry.” More than 30 guests from Asia, South America, North America and, last but not least, Europe exchanged views on the current state of developments and discussed future steps at the symposium. At the globally unique Technology Center the participants had the chance to get a first-hand impression of the sensor technology measurement, analysis and control technology in practical application. The QbCon ® pilot plant, which was developed in close cooperation with science and project partners from the industry, sets standards according to Prof. Peter Kleinebudde of 8 INNOVATIV 1 | 2018
The international participants listened closely to the explanations of Dr. Robin Meyer (to the right). The twin-screw granulator BCG, which has been presented as recently as in 2017 (to the left), was also met with great interest. Heinrich Heine University Düsseldorf. “The strength of the L.B. Bohle plant clearly is its modular design which enables both dry granulation and wet granulation.” The “point of no return” has already been passed. Tim Remmert is convinced of that as well: “There is a huge interest in continuous processes.” Experts all over the world no longer wonder whether, but when the breakthrough will come. “We like to compare the situation with e-mobility. But everybody in the industry knows: The “point of no return” has already been passed“. At the same time, all parties involved must be aware that perseverance is required due to the long-term planning of new production plants. L.B. Bohle has now combined all activities surrounding continuous processes under the umbrella name QbCon ® as a brand to strengthen Bohle’s position “QbCon ® stands for Quality by Continuous Manufacturing”, explains Dr. Robin Meier, Scientific Director, to the participants. Continuous manufacturing – the basis for success The central venue for the three-day expert symposium was the Technology Center. In the new building, L.B. Bohle has been offering an open platform for the development of innovative processes of continuous manufacturing since March 2015. Customers, scientists and cooperation partners INNOVATIV 1 | 2018 9